NANOBIOTIX Provides Business Update and Reports Full Year
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel...
Source: globenewswire.com
Bart Van Rhijn News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bart Van Rhijn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bart Van Rhijn Today - Breaking & Trending Today
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102 reinforces...
Source: marketscreener.com
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102 reinforces pivotal NANORAY-312 trial design in head and
Source: eagletribune.com
Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.
Aggregate gross proceeds of approximately €50.9 million received by NANOBIOTIX has increased to approximately €55.5 million extending its runway into mid’ 2025 PARIS and CAMBRIDGE, Mass.,...
Source: marketscreener.com
NANOBIOTIX Provides Third Quarter 2023 Operational and Financial Update
$2.5 billion global licensing, co-development, and commercialization agreement expands worldwide potential of novel radioenhancer NBTXR316.9 months median progression free survival (mPFS) and 23.1 months median overall survival (mOS) following radiotherapy-activated
Source: elpasoinc.com